RT Journal Article
SR Electronic
T1 Ankle proprioception in children with cerebral palsy
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.04.26.23289148
DO 10.1101/2023.04.26.23289148
A1 Boyer, Elizabeth
A1 Huang, Qiyin
A1 Ngwesse, Stacy
A1 Nelson, Jennifer
A1 Oh, Jinseok
A1 Konczak, Jürgen
YR 2023
UL http://medrxiv.org/content/early/2023/04/28/2023.04.26.23289148.abstract
AB Purpose There is no established clinical standard to evaluate ankle proprioception in children with cerebral palsy (CP). This study compared ankle position sense of children with CP to age-matched children typically developing (TD).Methods Children aged 6-17 years participated (15 CP, 58 TD). Using a custom-built device, the ankle was passively rotated to 2 positions for 25 trials. Using a psychophysical forced-choice paradigm, participants indicated which position was more plantarflexed. A psychometric function was fitted to the response data to determine the just noticeable difference (JND) threshold and the associated uncertainty (random error) for ankle position sense.Results Median JND thresholds for the CP group were elevated (CP: 4.3°, TD: 3.0°). Three children with CP exceeded the 95th percentile of TD. No differences in random error were found.Conclusion This method assessed ankle proprioception relative to norm data and identified position sense impairments in children with CP. Using this method can provide data on proprioceptive status in CP, augmenting the assessment of motor impairment.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Endowed Fund for Research in Cerebral Palsy Treatment and Gait and Motion Outcomes Fund of Gillette Childrens and research funds by Dr. Konczak. The device for assessing ankle proprioception was designed by the Human Sensorimotor Control Laboratory of University of Minnesota.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:These studies (STUDY00009461 and STUDY00003446) were approved by the University of Minnesota Institutional Review Board on May 15th, 2020 and May 3rd, 2019 respectively. Informed consent was obtained for all participants in both studies.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.